Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 964 | 1216 | 1022 | 1540 | 1921 |
Fund Return | 6.36% | -3.57% | 21.61% | 0.72% | 9.01% | 6.75% |
Place in category | 445 | 701 | 424 | 197 | 101 | 115 |
% in Category | 47 | 71 | 39 | 35 | 20 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund D div USD hedged | 17.91B | 9.46 | 2.07 | 3.79 | ||
JPI Global Income Fund A acc USD he | 17.91B | 9.76 | 2.45 | 4.17 | ||
JPI Global Income Fund A div USD he | 17.91B | 9.78 | 2.47 | 4.18 | ||
JPI Global Income Fund A mth USD he | 17.91B | 9.75 | 2.44 | 4.16 | ||
JPI Global Income Fund C acc USD he | 17.91B | 10.32 | 3.13 | 4.86 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund A2 | 6.78B | 8.78 | 3.01 | 8.01 | ||
World Healthscience Fund E2 | 2.21B | 8.32 | 2.49 | 7.47 | ||
LU1960219225 | 1.47B | 9.68 | 4.03 | - | ||
LU2112291526 | 769.05M | 8.79 | 2.99 | - | ||
World Healthscience Fund C2u | 388.57M | 7.65 | 1.73 | 6.66 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.85 | 788.19 | -0.14% | |
UnitedHealth | US91324P1021 | 7.98 | 608.38 | +0.26% | |
Novo Nordisk B | DK0062498333 | 5.92 | 743.4 | -2.03% | |
AbbVie | US00287Y1091 | 5.72 | 183.08 | +1.07% | |
Thermo Fisher Scientific | US8835561023 | 4.74 | 521.66 | +1.69% |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Neutral | Buy |
Technical Indicators | BUY | BUY | BUY | BUY | Strong Buy |
Summary | Buy | Buy | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review